Top Biotechnology & Medical Research stocks in Australia

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
au flag iconTLXTelix PharmaceuticalsAU$4.96bnn/an/a
au flag iconMSBMesoblastAU$2.73bnn/an/a
au flag iconCU6Clarity PharmaceuticalsAU$1.18bnn/an/a
au flag iconPYCPYC TherapeuticsAU$1.10bnn/an/a
au flag iconRACRacura OncologyAU$497.25mn/an/a
au flag iconCGSCogstateAU$394.58m26.470.81%
au flag iconTTXTetratherixAU$248.64mn/an/a
au flag iconDXBDimerixAU$204.13mn/an/a
au flag iconNYRNyradaAU$147.17mn/an/a
au flag iconBXNBioxyneAU$146.88m17.1n/a
au flag iconACWActinogen MedicalAU$121.10mn/an/a
au flag iconALAArovella TherapeuticsAU$111.71mn/an/a
au flag iconILAIsland PharmaceuticalsAU$99.55mn/an/a
au flag iconPARParadigm BiopharmaceuticalsAU$98.56mn/an/a
au flag iconATHAlterity TherapeuticsAU$97.88mn/an/a
au flag iconATXAmplia TherapeuticsAU$79.53mn/an/a
au flag iconLTPLtr PharmaAU$75.38mn/an/a
au flag iconCYPCynata TherapeuticsAU$70.05mn/an/a
au flag iconRHYRhythm BiosciencesAU$63.19mn/an/a
au flag iconGD8GO-DX (Aust)AU$61.94mn/an/a